The government has asked medical institutions for cooperation in making indiscriminate Wegovy prescriptions.

The Ministry of Health and Welfare said on the 11th through the medical community, “Regarding Wegovy, which was recently released as a treatment for obesity, medical institutions are issuing prescriptions without sufficiently examining the patient's condition, raising concerns of its abuse and misuse.” The ministry emphasized, ”Wegovy is administered as an aid for weight management for obese patients, and side effects may occur if used regardless of the patient's medical condition.”

The MOHW also asked institutions to comply with the MFDS’s approved indication, which